HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH PARKINSON'S DISEASE- A LONGITUDINAL STUDY

Author(s)

Gandhi AB1, Onukwugha E1, Albarmawi H1, Johnson A1, Myers DE2, Gray DL3, Alvir J4, Shulman LM5, Hynicka L1, Stuart B1
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2Pfizer, Inc., Collegeville, PA, USA, 3Pfizer Inc, Cambridge, MA, USA, 4Pfizer Inc, New York, NY, USA, 5University of Maryland School of Medicine, Baltimore, MD, USA

OBJECTIVES: Studies that report healthcare resource utilization (HcRU) among individuals diagnosed with Parkinson’s disease (PD) typically have short follow-up periods. Longitudinal information on HcRU is important given that PD evolves over time. This study's purpose was to investigate differences in HcRU for PD cases and controls over time.

METHODS: This retrospective study utilized administrative claims data from 2005 to 2015 for Medicare beneficiaries represented in the Medicare Chronic Condition Data Warehouse (CCW) 5% sample. We matched cases to controls based on age, race, gender and comorbidities. Differences in HcRU (hospitalization, skilled nursing facility (SNF), and non-PD drug utilization) were assessed during the follow-up period between PD cases and controls. For individuals with at least 1, 3, 5, 7 and 9 years of follow up, we calculated summary statistics based on proportions and counts of HcRU measures.

RESULTS: The matched sample consisted of 15,172 cases & 15,172 controls. Among those with 1 year of follow up, a higher proportion of PD cases experienced an inpatient hospitalization (20% vs. 10%, p-value: < 0.01). A similar pattern existed among those with 9 years of follow-up (56% vs. 43%, p-value: < 0.01). We observed a similar pattern for SNF stays based on 1 year of follow-up (24% vs. 7%, p-value: < 0.01) and 9 years of follow-up (51% vs 24%, p-value: < 0.01). PD cases displayed increased HcRU with longer follow-up periods. For PD cases, the median number of SNF stays was 0 among those with 1 year of follow-up and 4 among those with 9 years of follow-up, compared to controls where the median number of SNF stays remained 0 across the periods.

CONCLUSIONS: We characterized HcRU among a cohort of Medicare beneficiaries with and without Parkinson’s disease – related claims. Over time, PD cases consistently displayed higher HcRU as compared to controls.

Conference/Value in Health Info

2019-05, ISPOR 2019, New Orleans, LA, USA

Value in Health, Volume 22, Issue S1 (2019 May)

Code

PND17

Topic

Economic Evaluation, Real World Data & Information Systems

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies, Health & Insurance Records Systems

Disease

Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×